Evidence map›Paper›PMID 41145216›Full record

ArticleGenome research2025

Real-time analysis and visualization of nanopore metagenomic samples with MARTi.

Ned Peel, Samuel Martin, Darren Heavens, Douglas W Yu, Matthew D Clark, Richard M Leggett

Abstract read
In one paragraph

Article in Genome research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ned PeelEarlham Institute, Norwich, NR4 7UZ, United Kingdom.ORCID 0000-0002-7429-7009
Samuel MartinEarlham Institute, Norwich, NR4 7UZ, United Kingdom.ORCID 0000-0002-6298-1014
Darren HeavensEarlham Institute, Norwich, NR4 7UZ, United Kingdom.ORCID 0000-0001-5418-7868
Douglas W YuUniversity of East Anglia, Norwich, NR4 7TJ, United Kingdom.ORCID 0000-0001-8551-5609
Matthew D ClarkNatural History Museum, London, SW7 5BD, United Kingdom.ORCID 0000-0002-8049-5423
Richard M LeggettEarlham Institute, Norwich, NR4 7UZ, United Kingdom; richard.leggett@earlham.ac.uk.ORCID 0000-0003-3044-4297

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of nanopore sequencing technology has the potential to transform metagenomics by offering low-cost, portable, and long-read sequencing capabilities. Furthermore, these platforms enable real-time data generation, which could significantly reduce the time from sample collection to result, a crucial factor for point-of-care diagnostics and biosurveillance. However, the full potential of real-time metagenomics remains largely unfulfilled due to a lack of accessible, open-source bioinformatic tools. We present Metagenomic Analysis in Real-Time (MARTi), an innovative open-source software designed for the real-time analysis, visualization, and exploration of metagenomic data. MARTi supports various classification methods, including BLAST, Centrifuge, and Kraken2, letting users customize parameters and utilize their own databases for taxonomic classification and antimicrobial resistance analysis. With a user-friendly, browser-based graphical interface, MARTi provides dynamic, real-time updates on community composition and AMR gene identification. MARTi's architecture and operational flexibility make it suitable for diverse research applications, ranging from in-field analysis to large-scale metagenomic studies. Using both simulated and real-world data, we demonstrate MARTi's performance in read classification, taxon detection, and relative abundance estimation. By bridging the gap between sequencing and actionable insights, MARTi marks a significant advance in the accessibility and functionality of real-time metagenomic analysis.

Indexed as

MetagenomicsNanoporesNanopore SequencingSoftwareComputational BiologyHumansMetagenome

Identifiers

PMID41145216
PMCPMC12581910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.